KIM EARL: Open Payments
NPI 1063669497 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 64 payments from 11 companies in 2025. Trend: 2023 $1,617 · 2024 $1,782 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $376 |
| Axsome Therapeutics, Inc. | 9 | $242 |
| Alkermes, Inc. | 6 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Lundbeck LLC | 5 | $110 |
| Corium, LLC | 5 | $98 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, LYBALVI, Azstarys, INGREZZA, TRINTELLIX.
Industry payments across IL — which companies pay providers there.
